Robinhood stock slips as HOOD releases December trading snapshot and traders eye crypto softness

Robinhood Markets, Inc. shares eased on Wednesday after the trading app published a late-December snapshot of customer activity that investors watch for clues about quarter-end momentum.

NEW YORK, December 31, 2025, 12:46 ET — Regular session

  • HOOD shares edged down in midday trade after Robinhood published a late-December snapshot of trading volumes.
  • Robinhood said equity notional volume was about $170 billion from Dec. 1–28; options contracts traded were about 179 million.
  • Crypto notional volume was about $19 billion, while event contracts totaled about 2.6 billion.

Robinhood Markets, Inc. shares eased on Wednesday after the trading app published a late-December snapshot of customer activity that investors watch for clues about quarter-end momentum.

The update matters because Robinhood’s results are sensitive to trading activity, especially in options and cryptocurrency, where small changes in volumes can move transaction-based revenue.

With the year winding down, traders have been looking for signs that retail participation is holding up into quarter end, even as activity in digital assets has cooled from earlier peaks.

Robinhood shares were down about 0.3% at $115.11 in midday New York trading, after moving between $114.00 and $115.90 in the session.

In a statement released late Tuesday, Robinhood said equity “notional” trading volume — the total dollar value of stock trades — was about $170 billion from Dec. 1 through Dec. 28. Customers traded about 179 million options contracts, while crypto notional volume was about $19 billion, including roughly $7 billion on the Robinhood app and $12 billion on Bitstamp; event contracts totaled about 2.6 billion. The company said the figures were unaudited and preliminary, and that full December operating data will be released with its full-year and fourth-quarter earnings; it also said event contracts can trade in $0.01 increments up to $1 and are worth $1 on settlement. MarketScreener

For investors, those monthly-style reads are a shorthand for how Robinhood’s transaction revenue might be tracking ahead of the official earnings release, with options and crypto typically among the biggest swing factors.

Needham cut its price target on Robinhood to $135 from $145 while keeping a buy rating, in a broader cryptoasset-sector reset that flagged softer retail trading activity, TipRanks reported. “Even if crypto prices are near a bottom, retail volumes typically remain muted until momentum returns,” Needham analyst John Todaro wrote. TipRanks

Crypto-linked assets were weaker on Wednesday, a backdrop that tends to pressure retail trading platforms when activity slows. Bitcoin fell about 0.9% to $87,486, while Coinbase and Interactive Brokers were down about 1.0% and 0.2%, respectively.

Robinhood’s December snapshot also keeps attention on its newer prediction-markets business, where customers trade event contracts tied to the outcomes of real-world events and prices can move like implied probabilities.

Investors are now looking to the company’s full-year and fourth-quarter report for the final December operating data, plus any updated view on the mix between equities, options and crypto that can drive revenue per trade.

On the tape, traders were watching $114 as near-term support after Wednesday’s low, with $116 the next level to clear after the intraday high. Thin year-end liquidity can amplify moves around those levels.

Robinhood, best known for serving retail traders, has leaned on frequent product expansion to keep engagement up beyond the meme-stock era. Wednesday’s muted reaction suggests investors are waiting for confirmation that December’s activity carries through into the quarter-end results.

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech. Her coverage ranges from stocks and technology to emerging industries and developments across global markets. She studied economics and finance at the London School of Economics and worked in market research before becoming a financial journalist. Follow Khadija Saeed on Google News.

ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade
Previous Story

ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade

Meta stock slips after-hours as scam-ad scrutiny mounts, Manus AI deal draws focus
Next Story

Meta stock slips after-hours as scam-ad scrutiny mounts, Manus AI deal draws focus